Conversely, IRE1 overexpression in colon cancer cells resulted in reduced tumour progression and increased tumour‐infiltrating lymphocytes, thus providing an anti‐tumour role of IRE1, which triggers the immune response based on metabolic cues. Here, ERN1 is linked to colonic neoplasm.